A novel tumor-homing TRAIL variant eradicates tumor xenografts of refractory colorectal cancer cells in combination with tumor cell-targeted photodynamic therapy

• প্রধান লেখক: Zhao Li (লেখক), Tianshan She (লেখক), Hao Yang (লেখক), Tao Su (লেখক), Qiuxiao Shi (লেখক), Ze Tao (লেখক), Yanru Feng (লেখক), Fen Yang (লেখক), Jingqiu Cheng (লেখক), Xiaofeng Lu (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Taylor & Francis Group, 2022-12-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Multidrug resistance (MDR), which is common in colorectal cancer (CRC), induces high mortality in patients. Due to its robust and selective apoptosis induction in some CRC cells with MDR, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is attractive as a novel tool for CRC therapy. H...